Voya Financial Advisors, Inc. Amgen Inc Transaction History

Voya Financial Advisors, Inc.

$923 Million
Q3 2024

A detailed history of Voya Financial Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Voya Financial Advisors, Inc. holds 3,532 shares of AMGN stock, worth $915,847. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,532

Previous 4,081 13.45%

Holding current value

$915,847

Previous $1.28 Million 10.75%

% of portfolio

0.12%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $169,849 - $185,221	-549 Reduced 13.45%	3,532 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $124,806 - $151,672	475 Added 13.17%	4,081 $1.28 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $8,872 - $10,710	33 Added 0.92%	3,606 $1.03 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $86,682 - $97,787	-339 Reduced 8.67%	3,573 $1.03 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $10,495 - $13,030	48 Added 1.24%	3,912 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $82,708 - $97,800	386 Added 11.1%	3,864 $857,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $52,383 - $63,846	-232 Reduced 6.25%	3,478 $840,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $212,310 - $269,766	-927 Reduced 19.99%	3,710 $974,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $63,971 - $72,147	285 Added 6.55%	4,637 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $98,282 - $109,371	426 Added 10.85%	4,352 $1.07 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $140,990 - $155,972	643 Added 19.59%	3,926 $952,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $29,036 - $33,229	146 Added 4.65%	3,283 $744,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $8,490 - $9,948	-40 Reduced 1.26%	3,137 $674,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $6.39 Million - $7.09 Million	-27,375 Reduced 89.6%	3,177 $770,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $168,873 - $196,794	761 Added 2.55%	30,552 $7.63 Million
Q4 2020 Mar 05, 2021	SELL	$216.38 - $257.67 $24,234 - $28,859	-112 Reduced 0.37%	29,791 $6.77 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $829,018 - $921,936	-3,533 Reduced 10.57%	29,903 $7.43 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $231,833 - $284,491	1,172 Added 3.63%	33,436 $7.74 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $642,760 - $852,475	-3,527 Reduced 9.85%	32,264 $6.73 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.91 Million - $2.46 Million	10,099 Added 39.31%	35,791 $8.6 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $122,747 - $147,077	705 Added 2.82%	25,692 $5.01 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $323,898 - $379,681	1,943 Added 8.43%	24,987 $4.6 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $440,237 - $496,243	-2,434 Reduced 9.55%	23,044 $4.32 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1.1 Million - $1.28 Million	-6,155 Reduced 19.46%	25,478 $4.86 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $431,725 - $486,713	-2,330 Reduced 6.86%	31,633 $6.61 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $762,501 - $856,453	-4,592 Reduced 11.91%	33,963 $6.23 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $295,824 - $345,708	-1,746 Reduced 4.33%	38,555 $6.57 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $798,207 - $891,842	-4,729 Reduced 10.5%	40,301 $7.06 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $7.53 Million - $8.6 Million	45,030	45,030 $8.35 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.

Account

Voya Financial Advisors, Inc. Amgen Inc Transaction History